Meta-analysis of the effect of preoperative breast MRI on the surgical management of ductal carcinoma in situ

British Journal of Surgery

Volumn 102, Issue 8, 2015, Pages 883-893

  Fancellu, A ^a   Turner, R M ^b   Dixon, J M ^d   Pinna, A ^a   Cottu, P ^a   Houssami, N ^c  

^a UNIVERSITY OF SASSARI   (Italy)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASTECTOMY; MASTECTOMY, SEGMENTAL; META ANALYSIS; PATHOLOGY; PREOPERATIVE CARE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASTECTOMY; MASTECTOMY, SEGMENTAL; PREOPERATIVE CARE;

EID: 84931561338     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9797     Document Type: Review

References (57)

1. Schmale I, Liu S, Rayhanabad J, Russell CA, Sener SF,. Ductal carcinoma in situ (DCIS) of the breast: perspectives on biology and controversies in current management. J Surg Oncol 2012; 105: 212-220.
2. Meijnen P, Oldenburg HS, Peterse JL, Bartelink H, Rutgers EJ,. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast. Ann Surg Oncol 2008; 15: 235-243.
3. Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, van de Vijver MJ, etal. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 1994; 11: 167-180.
4. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
5. Virnig BA, Wang SY, Tuttle TM,. Ductal carcinoma in situ, and the influence of the mode of detection, population characteristics, and other risk factors. Am Soc Clin Oncol Educ Book 2012; 32: 45-48.
6. Estévez LG, Alvarez I, Seguí MÁ, Muñoz M, Margelí M, Mirõ C, etal. Current perspectives of treatment of ductal carcinoma in situ. Cancer Treat Rev 2010; 36: 507-517.
7. Leeper AD, Dixon JM,. DCIS of the breast: are we over-diagnosing it? Are we over-treating it? Maturitas 2011; 68: 295-296.
8. Jansen SA,. Ductal carcinoma in situ: detection, diagnosis, and characterization with magnetic resonance imaging. Semin Ultrasound CT MR 2011; 32: 306-318.
9. Itakura K, Lessing J, Sakata T, Heinzerling A, Vriens E, Wisner D, etal. The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ. Clin Breast Cancer 2011; 11: 33-38.
10. Pilewskie M, Kennedy C, Shappell C, Helenowski I, Scholtens D, Hansen N, etal. Effect of MRI on the management of ductal carcinoma in situ of the breast. Ann Surg Oncol 2013; 20: 1522-1529.
11. Yamada T, Mori N, Watanabe M, Kimijima I, Okumoto T, Seiji K, etal. Radiologic-pathologic correlation of ductal carcinoma in situ. Radiographics 2010; 30: 1183-1198.
12. Pilewskie M, Olcese C, Eaton A, Patil S, Morris E, Morrow M, etal. Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation. Ann Surg Oncol 2014; 21: 1552-1560.
13. Fancellu A, Soro D, Castiglia P, Marras V, Melis M, Cottu P, etal. Usefulness of magnetic resonance in patients with invasive cancer eligible for breast conservation: a comparative study. Clin Breast Cancer 2014; 14: 114-121.
14. Houssami N, Ciatto S, Macaskill P, Lord SJ, Warren RM, Dixon JM, etal. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008; 26: 3248-3258.
15. Houssami N, Morrow M,. Pre-operative breast MRI in women with recently diagnosed breast cancer-where to next? Breast 2010; 19: 1-2.
16. Morrow M, Waters J, Morris E,. MRI for breast cancer screening, diagnosis, and treatment. Lancet 2011; 378: 1804-1811.
17. Houssami N, Turner R, Macaskill P, Turnbull LW, McCready DR, Tuttle TM, etal. An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence. J Clin Oncol 2014; 32: 392-401.
18. Solin LJ, Orel SG, Hwang WT, Harris EE, Schnall MD,. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 2008; 26: 386-391.
19. McLaughlin S, Mittendorf EA, Bleicher RJ, McCready DR, King TA,. The 2013 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: MRI in breast cancer: where are we now? Ann Surg Oncol 2014; 21: 28-36.
20. Shin HC, Han W, Moon HG, Yom CK, Ahn SK, You JM, etal. Limited value and utility of breast MRI in patients undergoing breast-conserving cancer surgery. Ann Surg Oncol 2012; 19: 2572-2579.
21. Schouten van der Velden AP, Schlooz-Vries MS, Boetes C, Wobbes T,. Magnetic resonance imaging of ductal carcinoma in situ: what is its clinical application? A review. Am J Surg 2009; 198: 262-269.
22. Houssami N, Turner R, Morrow M,. Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg 2013; 257: 249-255.
23. Turnbull L, Brown S, Harvey I, Olivier C, Drew P, Napp V, etal. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomized controlled trial. Lancet 2010; 375: 563-571.
24. Peters NH, van Esser S, van den Bosch MA, Storm RK, Plaisier PW, van Dalen T, etal. Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET-randomised controlled trial. Eur J Cancer 2011; 47: 879-886.
25. Turnbull LW, Brown SR, Olivier C, Harvey I, Brown J, Drew P, etal. Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE). Health Technol Assess 2010; 14: 1-182.
26. Allen LR, Lago-Toro CE, Hughes JH, Careaga E, Brown AT, Chernick M, etal. Is there a role for MRI in the preoperative assessment of patients with DCIS? Ann Surg Oncol 2010; 17: 2395-2400.
27. Kropcho LC, Steen ST, Chung AP, Sim MS, Kirsch DL, Giuliano AE,. Preoperative breast MRI in the surgical treatment of ductal carcinoma in situ. Breast J 2012; 18: 151-156.
28. Davis KL, Barth RJ Jr, Gui J, Dann E, Eisenberg B, Rosenkranz K,. Use of MRI in preoperative planning for women with newly diagnosed DCIS: risk or benefit? Ann Surg Oncol 2012; 19: 3270-3274.
29. Obdeijn IM, Tilanus-Linthorst MM, Spronk S, van Deurzen CH, de Monye C, Hunink MG, etal. Preoperative breast MRI can reduce the rate of tumor-positive resection margins and reoperations in patients undergoing breast-conserving surgery. AJR Am J Roentgenol 2013; 200: 304-310.
30. Siegmann KC, Baur A, Vogel U, Kraemer B, Hahn M, Claussen CD,. Risk-benefit analysis of preoperative breast MRI in patients with primary breast cancer. Clin Radiol 2009; 64: 403-413.
31. Chung A, Saouaf R, Scharre K, Phillips E,. The impact of MRI on the treatment of DCIS. Am Surg 2005; 71: 705-710.
32. Raza S, Vallejo M, Chikarmane SA, Birdwell RL,. Pure ductal carcinoma in situ: a range of MRI features. AJR Am J Roentgenol 2008; 191: 689-699.
33. Hwang ES, Kinkel K, Esserman LJ, Lu Y, Weidner N, Hylton NM,. Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol 2003; 10: 381-388.
34. Menell JH, Morris EA, Dershaw DD, Abramson AF, Brogi E, Liberman L,. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 2005; 11: 382-390.
35. Brem RF, Fishman M, Rapelyea JA,. Detection of ductal carcinoma in situ with mammography, breast specific gamma imaging, and magnetic resonance imaging: a comparative study. Acad Radiol 2007; 14: 945-950.
36. Kapoor NS, Eaton A, King TA, Patil S, Stempel M, Morris E, etal. Should breast density influence patient selection for breast-conserving surgery? Ann Surg Oncol 2013; 20: 600-606.
37. Erbas B, Provenzano E, Armes J, Gertig D,. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat 2006; 97: 135-144.
38. Fentiman IS,. Lessons learned in breast cancer surgery. Br J Surg 2014; 101: 145-147.
39. Cuzik J, Sestak I, Pinder S, Ellis IO, Forsyth S, Bundred NJ, et al,. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long term results from the UK/ANZ DCIS trial. Lancet Oncol 2011; 12: 21-29.
40. de Roos MA, de Bock GH, Baas PC, de Munck L, Wiggers T, de Vries J,. Compliance with guidelines is related to better local recurrence-free survival in ductal carcinoma in situ. Br J Cancer 2005; 93: 1122-1127.
41. Fancellu A, Cottu P, Feo CF, Bertulu D, Giuliani G, Mulas S, etal. Sentinel node biopsy in early breast cancer: lessons learned from more than 1000 cases at a single institution. Tumori 2012; 98: 413-420.
42. Jeevan R, Cromwell DA, Trivella M, Lawrence G, Kearins O, Pereira J, etal. Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics. BMJ 2012; 345: e4505.
43. Bani MR, Lux MP, Heusinger K, Wenkel E, Magener A, Schulz-Wendtland R, etal. Factors correlating with reexcision after breast-conserving therapy. Eur J Surg Oncol 2009; 35: 32-37.
44. Mennella S, Garlaschi A, Paparo F, Perillo M, Celenza M, Massa T, etal. Magnetic resonance imaging of breast cancer: factors affecting the accuracy of preoperative lesion sizing. Acta Radiol 2014; [Epub ahead of print].
45. Kumar AS, Chen DF, Au A, Chen YY, Leung J, Garwood ER, etal. Biologic significance of false-positive magnetic resonance imaging enhancement in the setting of ductal carcinoma in situ. Am J Surg 2006; 192: 520-524.
46. Holland R, Hendriks JH, Vebeek AL, Mravunac M, Schuurmans Stekhoven JH,. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990; 335: 519-522.
47. Faverly DR, Burgers L, Bult P, Holland R,. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 1994; 11: 193-198.
48. Gentilini O, Botteri E, Rotmensz N, Da Lima L, Caliskan M, Garcia-Etienne CA, etal. Conservative surgery in patients with multifocal/multicentric breast cancer. Breast Cancer Res Treat 2009; 113: 577-583.
49. Lim W, Park EH, Choi SL, Seo JY, Kim HJ, Chang MA, etal. Breast conserving surgery for multifocal breast cancer. Ann Surg 2009; 249: 87-90.
50. Clough KB, Ihrai T, Oden S, Kaufman G, Massey E, Nos C,. Oncoplastic surgery for breast cancer based on tumour location and a quadrant-per-quadrant atlas. Br J Surg 2012; 99: 1389-1395.
51. Greenwood HI, Heller SL, Kim S, Sigmund EE, Shaylor SD, Moy L,. Ductal carcinoma in situ of the breasts: review of MR imaging features. Radiographics 2013; 33: 1569-1588.
52. Solin LJ, Gray R, Baehner FL, Butler SM, Hughes LL, Yoshizawa C, etal. A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst 2013; 105: 701-710.
53. Benson JR, Wishart GC,. Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery. Lancet Oncol 2013; 14: e348-e357.
54. Joh JE, Esposito NN, Kiluk JV, Laronga C, Lee MC, Loftus L, etal. The effect of oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor-positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists. Oncologist 2011; 16: 1520-1526.
55. Allred DC, Wu Y, Mao S, Nagtegaal ID, Lee S, Perou CM, etal. Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res 2008; 14: 370-378.
56. Polyak K., Molecular markers for the diagnosis and management of ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010; 41: 210-213.
57. Angarita FA, Acuna SA, Fonseca A, Crystal P, Escallon J,. Impact of preoperative breast MRIs on timing of surgery and type of intervention in newly diagnosed breast cancer patients. Ann Surg Oncol 2010; 17: 273-279.